Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Liposome-based CTCs detection

From: Innovative approach to the detection of circulating tumor biomarkers: multi-dimensional application of liposome technology

Method

Sample

Capture rate

Reaction time

References

Immunomagnetic liposome

Serum of NSCLC patients

90%

—

[55]

EVs-liposome camouflaging

Blood of melanoma-bearing mice

80%

40 min

[54]

Multimarker magnetic liposome

Blood of multi-tumor patients

80%−97.5%

35 min

[61]

Immunomagnetic liposome

Cerebrospinal Fluid and blood of brain tumors patients

92.4%

25–30 min

[62]

Amphiphilic liposome

Blood of multi-tumor patients

62.82%−89.09%

—

[63]

Liposome-tethered supported lipid bilayer

Cell and cancer patients’ blood

70%−78%

—

[64]

Magnetic capture column

Blood infused with cancer cells

80.7%

11 min

[65]

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X